Stiripentol
Sponsors
Mayo Clinic, University of Colorado, Denver, Children's Hospital Medical Center, Cincinnati, Cook Children's Health Care System, Assistance Publique - Hôpitaux de Paris
Conditions
Dravet SyndromeEpilepsyEpileptic Encephalopathies Associated With SCN1A MutationsHealthy VolunteersPharmacoresistant Focal EpilepsiesStatus Epilepticus
Phase 1
Phase 4
Unknown Phase
Stiripentol in Dravet Syndrome
NCT01533506
Start: 2012-02-29End: 2013-02-28Updated: 2013-02-28
Compassionate Use of Stiripentol in Dravet Syndrome
NCT01835314
Updated: 2019-10-04
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
NCT01983722
Updated: 2026-01-23
Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies
NCT02239276
Updated: 2020-02-05
Population Pharmacokinetics of Antiepileptic in Pediatrics
CompletedNCT03196466
Start: 2017-06-19End: 2023-06-15Updated: 2025-11-20
Stiripentol for the Treatment of Refractory Status Epilepticus
CompletedNCT06540378
Start: 2013-01-01End: 2024-05-31Updated: 2024-08-06